Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
DISASTERS AVERTED — Near Miss Case Studies
Sometimes Long-term Patient/Healthcare Provider Relationship Must Be Severed
TOP STORIES — Diabetes News and Research
Using SGLT-2 Inhibitors to Significantly Reduce AFib
Analysis of Sotagliflozin’s Effect on Cardiorenal Factors for Type 1 Patients
Down Syndrome Youth Have a High Prevalence of Dyslipidemia and Prediabetes
MOST POPULAR ARTICLES OF THE MONTH
#1 Critical Changes to the 2021 ADA Standards of Care
#2 Omnipod Horizon System in Children with Type 1 Diabetes
#3 Sure, You May Lose Weight, But Will Going Low-Carb Impact Your Performance?
Letter from the Editor
It looks like the pandemic has had a significant effect on patients, as some providers are no longer participating in some health plans due to changes in reimbursement for chronic disease care. If you are one of these prescribers who have had to make a change, you may find that some of your patients are not going to be able to come to you. If you add this to the fact that many people have had to change coverage plans due to layoffs or business closings or new jobs, there is even a greater chance that they will unwillingly have to change their provider selection.
This week one of our many contributing practitioners shares their experience with a long term patient that was forced to change plans, and how she advised the patient on how to move forward.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief
DISASTERS AVERTED — Near Miss Case Studies
I am a primary care provider in a small private office. A long-term patient of mine, 32 years of age, was recently diagnosed with type 1 diabetes. His insurance is now one I do not participate in. Until his recent diagnosis, he visited annually and paid out of pocket. He wanted to stay with me for his care….
TOP STORIES — Diabetes News and Research
Diabetes causes metabolic changes that promote oxidative stress within the heart, resulting in changes that can impede its electrical signaling.
Can use of the sodium-glucose cotransporter 1 and sodium-glucose cotransporter 2 dual inhibitor in patients with type 1 diabetes preserve kidney function?
Two-thirds of youth with Down syndrome have a BMI percentile at or above 85, but is this a marker for prediabetes and dyslipidemia in this population?